Correlation of Plasma FL Expression with Bone Marrow Irradiation Dose

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Sproull, Mary ^a   Avondoglio, Dane ^a   Kramp, Tamalee ^a   Shankavaram, Uma ^a   Camphausen, Kevin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FMS LIKE TYROSINE KINASE 3 LIGAND; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; BONE MARROW; CONTROLLED STUDY; DOSIMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MOUSE; NONHUMAN; PARTIAL BODY RADIATION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIATION EXPOSURE; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; MEMBRANE PROTEINS; MICE; RADIATION DOSAGE; TIME FACTORS; WHOLE-BODY IRRADIATION;

EID: 84874711190     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058558     Document Type: Article

References (49)

1. Bourland J (2007) Radiation Oncology Physics. In: Gunderson LL TJ, editor. Clinical Radiation Oncology. Philedelphia: Churchill Livingstone. 111-168.
2. Shank B (2007) Total Body Irradiation. In: Gunderson LL TJ, editor. Clinical Radiation Oncology. Philadelphia: Churchill Livingstone. 343-364.
3. Down JD, Tarbell NJ, Thames HD, Mauch PM, (1991) Syngeneic and allogeneic bone marrow engraftment after total body irradiation: dependence on dose, dose rate, and fractionation. Blood 77: 661-669.
4. Davies SM, Ramsay NK, Klein JP, Weisdorf DJ, Bolwell B, et al. (2000) Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. J Clin Oncol 18: 340-347.
5. Fichelson S, (1998) The FLT3/FLK2 ligand: structure, functions and prospects. Eur Cytokine Netw 9: 7-22.
6. McClanahan T, Culpepper J, Campbell D, Wagner J, Franz-Bacon K, et al. (1996) Biochemical and genetic characterization of multiple splice variants of the Flt3 ligand. Blood 88: 3371-3382.
7. Lyman SD, Stocking K, Davison B, Fletcher F, Johnson L, et al. (1995) Structural analysis of human and murine flt3 ligand genomic loci. Oncogene 11: 1165-1172.
8. Lyman SD, Brasel K, Rousseau AM, Williams DE (1994) The flt3 ligand: a hematopoietic stem cell factor whose activities are distinct from steel factor. Stem Cells 12 Suppl 1: 99-107; discussion 108-110.
9. Huchet A, Belkacemi Y, Frick J, Prat M, Muresan-Kloos I, et al. (2003) Plasma Flt-3 ligand concentration correlated with radiation-induced bone marrow damage during local fractionated radiotherapy. Int J Radiat Oncol Biol Phys 57: 508-515.
10. Prat M, Frick J, Laporte JP, Thierry D, Gorin NC, et al. (2006) Kinetics of plasma FLT3 ligand concentration in hematopoietic stem cell transplanted patients. Leuk Lymphoma 47: 77-80.
11. Bertho JM, Roy L, Souidi M, Benderitter M, Bey E, et al. (2009) Initial evaluation and follow-up of acute radiation syndrome in two patients from the Dakar accident. Biomarkers 14: 94-102.
12. Bertho JM, Roy L, Souidi M, Benderitter M, Gueguen Y, et al. (2008) New biological indicators to evaluate and monitor radiation-induced damage: an accident case report. Radiat Res 169: 543-550.
13. Bertho JM, Roy L, (2009) A rapid multiparametric method for victim triage in cases of accidental protracted irradiation or delayed analysis. Br J Radiol 82: 764-770.
14. Kirk MJ, Hayward RM, Sproull M, Scott T, Smith S, et al. (2008) Non-patient related variables affecting levels of vascular endothelial growth factor in urine biospecimens. J Cell Mol Med 12: 1250-1255.
15. Hayward RM, Kirk MJ, Sproull M, Scott T, Smith S, et al. (2008) Post-collection, pre-measurement variables affecting VEGF levels in urine biospecimens. J Cell Mol Med 12: 343-350.
16. Forman S (2008) Hematopoietic cell transplantation. In: Pazdur R, Wagman, LD, Camphausen, KA, Hoskins, WJ, editor. Cancer Management: A Multidisciplinary Approach. Lawrence: CMP Healthcare Media. 877-895.
17. Kun L (2005) Leukemias in children. In: Halperin E, Constine, LS, Tarbell, NJ, Kun, LE, editor. Pediatric Radiation Oncology. Philedephia: Lippincott Williams & Wilkins. 15-88.
18. Harden SV, Routsis DS, Geater AR, Thomas SJ, Coles C, et al. (2001) Total body irradiation using a modified standing technique: a single institution 7 year experience. Br J Radiol 74: 1041-1047.
19. Adkins DR, DiPersio JF, (2008) Total body irradiation before an allogeneic stem cell transplantation: is there a magic dose? Curr Opin Hematol 15: 555-560.
20. Fish J (2012) Long-term effects of bone marrow transplantation. Medscape: Emedecine.
21. Wodnar-Filipowicz A, Lyman SD, Gratwohl A, Tichelli A, Speck B, et al. (1996) Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia. Blood 88: 4493-4499.
22. Chklovskaia E, Jansen W, Nissen C, Lyman SD, Rahner C, et al. (1999) Mechanism of flt3 ligand expression in bone marrow failure: translocation from intracellular stores to the surface of T lymphocytes after chemotherapy-induced suppression of hematopoiesis. Blood 93: 2595-2604.
23. Wodnar-Filipowicz A, (2003) Flt3 ligand: role in control of hematopoietic and immune functions of the bone marrow. News Physiol Sci 18: 247-251.
24. Bertho JM, Demarquay C, Frick J, Joubert C, Arenales S, et al. (2001) Level of Flt3-ligand in plasma: a possible new bio-indicator for radiation-induced aplasia. Int J Radiat Biol 77: 703-712.
25. Partridge MA, Chai Y, Zhou H, Hei TK, (2010) High-throughput antibody-based assays to identify and quantify radiation-responsive protein biomarkers. Int J Radiat Biol 86: 321-328.
26. Blakely WF, Sandgren DJ, Nagy V, Kim S, Ossetrova NI, (2011) Murine partial-body radiation exposure model for biodosimetry studies - Preliminary reporRadiat Meas. 46: 898-902.
27. Prat M, Demarquay C, Frick J, Dudoignon N, Thierry D, et al. (2006) Use of flt3 ligand to evaluate residual hematopoiesis after heterogeneous irradiation in mice. Radiat Res 166: 504-511.
28. Snyder W, Cook MJ, Nasset ES, Karhausen LR, Howells GP, et al. (1975) Report of the Task Group on Referemce Man. Oxford: Pergamon Press.
29. Shaposhnikov V (1979) Distribution of bone marrow cells in the mouse skeleton. In: Yarigin V, editor. Bulletin of Experimental Biology and Medecine: Springer. 510-512.
30. Poujol C, Tronik-Le Roux D, Tropel P, Roullot V, Nurden A, et al. (1998) Ultrastructural analysis of bone marrow hematopoiesis in mice transgenic for the thymidine kinase gene driven by the alpha IIb promoter. Blood 92: 2012-2023.
31. Iversen PO, Woldbaek PR, Tonnessen T, Christensen G, (2002) Decreased hematopoiesis in bone marrow of mice with congestive heart failure. Am J Physiol Regul Integr Comp Physiol 282: R166-172.
32. Iwashita T, Tada T, Zhan H, Tanaka Y, Hongo K, (2003) Harvesting blood stem cells from cranial bone at craniotomy-a preliminary study. J Neurooncol 64: 265-270.
33. Williams W, Nelson DA. (1995) Examination of the marrow. In: Beulter W, Lichtman, E, Coller, MA, Kipps, BS, editor. Hematology. New York: McGraw-Hill. 15-22.
34. Kricun ME, (1985) Red-yellow marrow conversion: its effect on the location of some solitary bone lesions. Skeletal Radiol 14: 10-19.
35. Gourmelon P, Benderitter M, Bertho JM, Huet C, Gorin NC, et al. (2010) European consensus on the medical management of acute radiation syndrome and analysis of the radiation accidents in Belgium and Senegal. Health Phys 98: 825-832.
36. Ivey RG, Subramanian O, Lorentzen TD, Paulovich AG, (2009) Antibody-based screen for ionizing radiation-dependent changes in the Mammalian proteome for use in biodosimetry. Radiat Res 171: 549-561.
37. Dainiak N, Berger P, Albanese J, (2007) Relevance and feasibility of multi-parameter assessment for management of mass casualties from a radiological event. Exp Hematol 35: 17-23.
38. Koenig KL, Goans RE, Hatchett RJ, Mettler FA Jr, Schumacher TA, et al. (2005) Medical treatment of radiological casualties: current concepts. Ann Emerg Med 45: 643-652.
39. Waller E, Millage K, Blakely WF, Ross JA, Mercier JR, et al. (2009) Overview of hazard assessment and emergency planning software of use to RN first responders. Health Phys 97: 145-156.
40. Meineke V, Fliedner TM (2005) Radiation-induced multi-organ involvement and failure: challenges for radiation accident medical management and future research. BJR Suppl 27: 196-200.
41. Mauch P, Constine L, Greenberger J, Knospe W, Sullivan J, et al. (1995) Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. Int J Radiat Oncol Biol Phys 31: 1319-1339.
42. Prat M, Demarquay C, Frick J, Thierry D, Gorin NC, et al. (2005) Radiation-induced increase in plasma Flt3 ligand concentration in mice: evidence for the implication of several cell types. Radiat Res 163: 408-417.
43. Fliedner TM, Graessle D, Paulsen C, Reimers K, (2002) Structure and function of bone marrow hemopoiesis: mechanisms of response to ionizing radiation exposure. Cancer Biother Radiopharm 17: 405-426.
44. Corvo R, Paoli G, Barra S, Bacigalupo A, Van Lint MT, et al. (1999) Total body irradiation correlates with chronic graft versus host disease and affects prognosis of patients with acute lymphoblastic leukemia receiving an HLA identical allogeneic bone marrow transplant. Int J Radiat Oncol Biol Phys 43: 497-503.
45. Bieri S, Helg C, Chapuis B, Miralbell R, (2001) Total body irradiation before allogeneic bone marrow transplantation: is more dose better? Int J Radiat Oncol Biol Phys 49: 1071-1077.
46. Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, Demirer T, Dini G, et al. (2006) Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 37: 439-449.
47. Siegel JA, Yeldell D, Goldenberg DM, Stabin MG, Sparks RB, et al. (2003) Red marrow radiation dose adjustment using plasma FLT3-L cytokine levels: improved correlations between hematologic toxicity and bone marrow dose for radioimmunotherapy patients. J Nucl Med 44: 67-76.
48. Blumenthal RD, Lew W, Juweid M, Alisauskas R, Ying Z, et al. (2000) Plasma FLT3-L levels predict bone marrow recovery from myelosuppressive therapy. Cancer 88: 333-343.
49. Gratwohl A, John L, Baldomero H, Roth J, Tichelli A, et al. (1998) FLT-3 ligand provides hematopoietic protection from total body irradiation in rabbits. Blood 92: 765-769.